These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4060594)

  • 21. U3 sequences from HTLV-I and -II LTRs confer pX protein response to a murine leukemia virus LTR.
    Kitado H; Chen IS; Shah NP; Cann AJ; Shimotohno K; Fan H
    Science; 1987 Feb; 235(4791):901-4. PubMed ID: 3027896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus.
    Nishigaki K; Hanson C; Thompson D; Yugawa T; Hisasue M; Tsujimoto H; Ruscetti S
    J Virol; 2002 Feb; 76(3):1527-32. PubMed ID: 11773427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter and enhancer activities of long terminal repeats associated with cellular retrovirus-like (VL30) elements.
    Rotman G; Itin A; Keshet E
    Nucleic Acids Res; 1986 Jan; 14(2):645-58. PubMed ID: 3456150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleotide sequence of the Rauscher murine leukaemia virus long terminal repeat.
    van der Feltz MJ; Kranendonk-Odijk ME; Stark J; de Both NJ
    J Gen Virol; 1986 Dec; 67 ( Pt 12)():2785-90. PubMed ID: 3794666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An enhancer "core" DNA-binding and transcriptional activity is induced upon transformation of rat embryo fibroblasts.
    Halazonetis TD
    Anticancer Res; 1992; 12(2):285-91. PubMed ID: 1580545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of an endogenous retrovirus enhancer by insertion into a heterologous context.
    Conklin KF
    J Virol; 1991 May; 65(5):2525-32. PubMed ID: 1850026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long terminal repeat of Friend-MCF virus contains the sequence responsible for erythroid leukemia.
    Ishimoto A; Adachi A; Sakai K; Matsuyama M
    Virology; 1985 Feb; 141(1):30-42. PubMed ID: 3856371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
    Green PL; Kaehler DA; McKearn J; Risser R
    Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic basis of disease specificity of nondefective Friend murine leukemia virus.
    Hopkins N
    Ann N Y Acad Sci; 1989; 567():14-25. PubMed ID: 2679314
    [No Abstract]   [Full Text] [Related]  

  • 30. Differences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells.
    LoSardo JE; Cupelli LA; Short MK; Berman JW; Lenz J
    J Virol; 1989 Mar; 63(3):1087-94. PubMed ID: 2644446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a protein that binds multiple sequences in mammalian type C retrovirus enhancers.
    Sun W; O'Connell M; Speck NA
    J Virol; 1993 Apr; 67(4):1976-86. PubMed ID: 8445719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Slipped DNA structures within the enhancer region of the Moloney murine leukemia virus.
    Gama Sosa MA; Hall JC; Ruprecht RM
    Biochem Biophys Res Commun; 1988 Oct; 156(1):417-23. PubMed ID: 3052452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping of functional regions of murine retrovirus long terminal repeat enhancers: enhancer domains interact and are not independent in their contributions to enhancer activity.
    Hollon T; Yoshimura FK
    J Virol; 1989 Aug; 63(8):3353-61. PubMed ID: 2545910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoid responsiveness of the transcriptional enhancer of Moloney murine sarcoma virus.
    Miksicek R; Heber A; Schmid W; Danesch U; Posseckert G; Beato M; Schütz G
    Cell; 1986 Jul; 46(2):283-90. PubMed ID: 3013424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancer sequences of a retroviral vector determine expression of a gene in multipotent hematopoietic progenitors and committed erythroid cells.
    Holland CA; Anklesaria P; Sakakeeny MA; Greenberger JS
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8662-6. PubMed ID: 2825203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear factor-1 (NF-1) binds to multiple sites within the transcriptional enhancer of Moloney murine leukemia virus.
    Reisman D
    FEBS Lett; 1990 Dec; 277(1-2):209-11. PubMed ID: 2269357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity.
    Speck NA; Renjifo B; Golemis E; Fredrickson TN; Hartley JW; Hopkins N
    Genes Dev; 1990 Feb; 4(2):233-42. PubMed ID: 2338244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukemogenicity of Moloney murine leukemia viruses carrying polyoma enhancer sequences in the long terminal repeat is dependent on the nature of the inserted polyoma sequences.
    Fan H; Chute H; Chao E; Pattengale PK
    Virology; 1988 Sep; 166(1):58-65. PubMed ID: 2842957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rat cellular mutants for expression of mRNA from the long terminal repeat of murine retrovirus.
    Isaka M; Inoue H; Tsukiyama T; Niwa O; Hakura A
    Virology; 1992 Jul; 189(1):141-9. PubMed ID: 1604805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.
    Derse D; Casey JW
    Science; 1986 Mar; 231(4744):1437-40. PubMed ID: 3006241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.